<?xml version="1.0" ?>
<TABLE>
<ENTRY>
<ID>CHEBI:67168</ID>
<NAME>UDP-N-acetyl-alpha-D-galactosamine</NAME>
<DEFINITION>A UDP-N-acetyl-D-galactosamine in which the anomeric centre of the galactosamine moiety has Î±-configuration.</DEFINITION>
<STAR>3</STAR>
<SECONDARY_ID>CHEBI:46285</SECONDARY_ID>
<SYNONYM>URIDINE-DIPHOSPHATE-N-ACETYLGALACTOSAMINE</SYNONYM>
<SYNONYM>UDP-GalNac</SYNONYM>
<SYNONYM>(2R,3R,4R,5R,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)</SYNONYM>
<IUPAC_NAME>uridine 5'-[3-(2-acetamido-2-deoxy-alpha-D-galactopyranosyl) dihydrogen diphosphate]</IUPAC_NAME>
<FORMULA>C17H27N3O17P2</FORMULA>
<MASS>607.35370</MASS>
<MONOISOTOPIC_MASS>607.082</MONOISOTOPIC_MASS>
<CHARGE>0</CHARGE>
<SMILES>CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(=O)[nH]c1=O</SMILES>
<INCHI>InChI=1S/C17H27N3O17P2/c1-6(22)18-10-13(26)11(24)7(4-21)35-16(10)36-39(31,32)37-38(29,30)33-5-8-12(25)14(27)15(34-8)20-3-2-9(23)19-17(20)28/h2-3,7-8,10-16,21,24-27H,4-5H2,1H3,(H,18,22)(H,29,30)(H,31,32)(H,19,23,28)/t7-,8-,10-,11+,12-,13-,14-,15-,16-/m1/s1</INCHI>
<INCHIKEY>LFTYTUAZOPRMMI-NESSUJCYSA-N</INCHIKEY>
<CAS_REGISTRY_NUMBER>7277-98-7</CAS_REGISTRY_NUMBER>
<REAXYS_REGISTRY_NUMBER>78983</REAXYS_REGISTRY_NUMBER>
<CHEMIDPLUS>7277-98-7</CHEMIDPLUS>
<HMDB_ACCESSION>HMDB0000304</HMDB_ACCESSION>
<KEGG_COMPOUND_ACCESSION>C00203</KEGG_COMPOUND_ACCESSION>
<KEGG_GLYCAN_ACCESSION>G10611</KEGG_GLYCAN_ACCESSION>
<METACYC_ACCESSION>UDP-N-ACETYL-GALACTOSAMINE</METACYC_ACCESSION>
<PDBECHEM_ACCESSION>UD2</PDBECHEM_ACCESSION>
<PUBMED_CITATION>10547037</PUBMED_CITATION>
<PUBMED_CITATION>12634319</PUBMED_CITATION>
<PUBMED_CITATION>13851695</PUBMED_CITATION>
</ENTRY>
</TABLE>